FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
Comparision between Exxaro Tiles IPO and Tatva Chintan Pharma IPO.
Exxaro Tiles IPO is a Mainline Book Built Issue IPO proposed to list at BSE, NSE while Tatva Chintan Pharma IPO is a Mainline Book Built Issue proposed to list at BSE, NSE.
Exxaro Tiles IPO | Tatva Chintan Pharma IPO | |
---|---|---|
Logo | ||
Issue Category | Mainline | Mainline |
Issue Type | IPO | IPO |
Process Type | Book Built Issue | Book Built Issue |
Listing At | BSE, NSE | BSE, NSE |
Lead Managers | Pantomath Capital Advisors Pvt Ltd | ICICI Securities Limited Jm Financial Limited |
Registrar | Link Intime India Private Ltd | Link Intime India Private Ltd |
Market Maker | ||
DRHP | DRHP | DRHP |
RHP | RHP | RHP |
Anchor Investor | ||
IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of Exxaro Tiles IPO is up to ₹161.09 Cr whereas the issue size of the Tatva Chintan Pharma IPO is up to ₹500.00 Cr. The final issue price of Exxaro Tiles IPO is ₹120.00 per share and of Tatva Chintan Pharma IPO is ₹1,083.00 per share.
Exxaro Tiles IPO | Tatva Chintan Pharma IPO | |
---|---|---|
Face Value | ₹10 per share | ₹10 per share |
Issue Price (Lower) | ₹118.00 per share | ₹1,073.00 per share |
Issue Price (Upper) | ₹120.00 per share | ₹1,083.00 per share |
Issue Price (Final) | ₹120.00 per share | ₹1,083.00 per share |
Discount (Retail) | ||
Discount (Employee) | ₹12.00 per share | |
Market Lot Size | 125 shares | 13 shares |
Fresh Issue Size | 1,11,86,000 shares | |
Fresh Issue Size (Amount) | up to ₹134.23 Cr | up to ₹225.00 Cr |
OFS Issue Size | 22,38,000 shares | |
OFS Issue Size (Amount) | up to ₹26.86 Cr | up to ₹275.00 Cr |
Issue Size Total | 1,34,24,000 shares | |
Issue Size Total (Amount) | up to ₹161.09 Cr | up to ₹500.00 Cr |
Exxaro Tiles IPO opens on Aug 04, 2021, while Tatva Chintan Pharma IPO opens on Jul 16, 2021. The closing date of Exxaro Tiles IPO and Tatva Chintan Pharma IPO is Aug 06, 2021, and Jul 20, 2021, respectively.
Exxaro Tiles IPO | Tatva Chintan Pharma IPO | |
---|---|---|
Anchor Bid Date | ||
Issue Open | Aug 04, 2021 | Jul 16, 2021 |
Issue Close | Aug 06, 2021 | Jul 20, 2021 |
Basis Of Allotment (Tentative) | Aug 11, 2021 | Jul 26, 2021 |
Initiation of Refunds (Tentative) | Aug 12, 2021 | Jul 27, 2021 |
Credit of Share (Tentative) | Aug 13, 2021 | Jul 28, 2021 |
Listing date (Tentative) | Aug 16, 2021 | Jul 29, 2021 |
Anchor Lockin End date 1 | Sep 10, 2021 | Aug 25, 2021 |
Anchor Lockin End date 2 | Nov 09, 2021 | Oct 24, 2021 |
Exxaro Tiles IPO P/E ratio is , as compared to Tatva Chintan Pharma IPO P/E ratio of .
Exxaro Tiles IPO | Tatva Chintan Pharma IPO | |||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Financial |
|
|
||||||||||||||||||||||||||||||||||||||||||||
Promoter Shareholding (Pre-Issue) | 56.09% | 100% | ||||||||||||||||||||||||||||||||||||||||||||
Promoter Shareholding (Post-Issue) | 42.5% | 79.17% | ||||||||||||||||||||||||||||||||||||||||||||
P/E Ratio | ||||||||||||||||||||||||||||||||||||||||||||||
Market Cap | ||||||||||||||||||||||||||||||||||||||||||||||
ROE | ||||||||||||||||||||||||||||||||||||||||||||||
ROCE | ||||||||||||||||||||||||||||||||||||||||||||||
Debt/Equity | ||||||||||||||||||||||||||||||||||||||||||||||
EPS | ||||||||||||||||||||||||||||||||||||||||||||||
RoNW |
In the Exxaro Tiles IPO retail investors (RII) are offered 52,62,200 shares while in Tatva Chintan Pharma IPO retail investors are offered 52,62,200 shares. Qualified institutional buyers (QIB) are offered 13,15,550 shares in Exxaro Tiles IPO and 9,31,966 shares in Tatva Chintan Pharma IPO.
Exxaro Tiles IPO | Tatva Chintan Pharma IPO | |
---|---|---|
Anchor Investor Reserveration | ||
Market Maker Reserveration | ||
QIB | 13,15,550 shares | 9,31,966 shares |
NII | 46,04,425 shares | 6,98,975 shares |
RII | 52,62,200 shares | 16,30,941 shares |
Employee | 2,68,500 shares | 0 shares |
Others | ||
Total | 1,14,50,675 shares | 32,61,882 shares |
Exxaro Tiles IPO subscribed 22.65x in total, whereas Tatva Chintan Pharma IPO subscribed 180.36x.
Exxaro Tiles IPO | Tatva Chintan Pharma IPO | |
---|---|---|
QIB (times) | 17.67x | 185.23x |
NII (times) | 5.36x | 512.22x |
Big NII (times) | ||
Small NII (times) | ||
RII (times) | 40.05x | 35.35x |
Employee (times) | 2.53x | |
Other (times) | ||
Total (times) | 22.65x | 180.36x |
Add a public comment...
Rs 0 Account Opening Fee
Free Eq Delivery & MF
Flat ₹20 Per Trade in F&O
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|